Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/1999
04/13/1999CA1340493C Pyridone carboxylic acid derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same
04/13/1999CA1340492C Novel naphthyridine-and quinoline-carboxylic acids as bacterial agents
04/10/1999CA2246632A1 Novel mure
04/09/1999CA2246635A1 Novel glucosaminidase
04/08/1999WO1999016884A1 Fusion proteins comprising hiv-1 tat and/or nef proteins
04/08/1999WO1999016881A1 Antigen protein and nucleic acid coding for said protein
04/08/1999WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists
04/08/1999WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists
04/08/1999WO1999016779A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
04/08/1999WO1999016778A1 Cyclic phosphites and phosphates
04/08/1999WO1999016753A2 Tricyclic 3-oxo-propanenitrile compounds
04/08/1999WO1999016710A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus
04/08/1999WO1999016466A2 Vaccine compositions and methods of enhancing vaccine efficacy
04/08/1999WO1999016460A2 Apolipoprotein e/growth factor complexes and methods of use
04/08/1999WO1999016418A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
04/08/1999WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
04/08/1999WO1999016408A2 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
04/08/1999WO1999016309A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
04/08/1999WO1999005269A3 Transcriptional silencer protein nrf
04/08/1999WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
04/08/1999WO1999003489A3 Methods and compositions for regulating nuclear trafficking of proteins
04/08/1999WO1999003488A3 Biologically active peptides with reduced toxicity in animals and a method for preparing same
04/08/1999WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response
04/08/1999WO1998054161A9 Oxazolidinone antibacterial agents having a thiocarbonyl functionality
04/08/1999WO1998035694A9 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
04/08/1999CA2305017A1 Amino-terminally truncated mcp-2 as chemokine antagonists
04/08/1999CA2304931A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
04/08/1999CA2304827A1 Amino-terminally truncated rantes as chemokine antagonists
04/08/1999CA2304814A1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
04/08/1999CA2304720A1 Apolipoprotein e/growth factor complexes and methods of use
04/08/1999CA2304665A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus
04/08/1999CA2304058A1 Cyclic phosphites and phosphates
04/08/1999CA2303930A1 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
04/08/1999CA2302025A1 Tricyclic 3-oxo-propanenitrile compounds
04/08/1999CA2245937A1 Novel histidine kinase
04/08/1999CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5
04/07/1999EP0906959A2 Aminopeptidase from Staphylococcus aureus
04/07/1999EP0906958A2 Staphylococcus peptidyl-tRNA hydrolase (Pth)
04/07/1999EP0906957A2 Lgt polypeptide
04/07/1999EP0906956A2 MurD from Streptococcus pneumoniae
04/07/1999EP0906955A2 FtsY
04/07/1999EP0906909A1 Novel hydroxy and polyhydroxy derivatives of coumarin, peperation thereof and antiviral action thereof
04/07/1999EP0906724A1 Pseudoplastic film-forming acidic chlorite composition as teat dip
04/07/1999EP0906421A1 Enhanced efficacy of liposomal antisense delivery
04/07/1999EP0906335A1 Ebv ctl epitopes
04/07/1999EP0906330A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
04/07/1999EP0906326A1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
04/07/1999EP0906317A1 Novel water-soluble c-ring analogues of 20(s)-camptothecin
04/07/1999EP0906316A1 Novel water-soluble analogues of 20(s)-camptothecin
04/07/1999EP0906313A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
04/07/1999EP0906307A1 Substituted imidazoles having cytokine inhibitory activity
04/07/1999EP0906303A1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/07/1999EP0906276A1 Novel vitamin d analogues
04/07/1999EP0906122A2 Activated linkers and methods for making and purifying the same
04/07/1999EP0906119A1 Method of treatment
04/07/1999EP0906111A1 Composition and method for treating herpes simplex
04/07/1999EP0906110A1 Dna vaccine formulations
04/07/1999EP0906107A1 Compositions comprising an hiv protease inhibitor such as vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs
04/07/1999EP0906098A1 Virginiamycin mixture
04/07/1999EP0906097A1 Anti-viral compounds
04/07/1999EP0906089A2 Buccal delivery system
04/07/1999EP0906088A1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity
04/07/1999EP0906019A1 LIVE ATTENUATED VACCINES BASED ON cp45 HPIV-3 STRAIN AND METHOD TO ENSURE ATTENUATION IN SUCH VACCINES
04/07/1999EP0799233B1 Diclavulanic acid salts with diamino ethers and process for their preparation
04/07/1999EP0738261B1 Pharmaceutical formulations comprising polythiourea and method of use thereof
04/07/1999EP0705264B1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
04/07/1999EP0683776B1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria
04/07/1999EP0659181B1 Sulfonamide inhibitors of hiv-aspartyl protease
04/07/1999EP0647266B1 D-enzyme compositions and methods of their use
04/07/1999EP0620821B1 Antiviral compositions and method for their use
04/07/1999EP0481994B1 Metallo-organic cobalt compounds and uses thereof
04/07/1999CN1213402A Recombinant expression of S-layer proteins
04/07/1999CN1213401A Exodus chemokine materials and method
04/07/1999CN1213307A Novel substituted imidazolium compounds
04/07/1999CN1213306A Novel substituted imidazolium compounds
04/07/1999CA2249715A1 Abc transporter
04/06/1999US5892040 Process for the manufacture of a tricyclic compound
04/06/1999US5892036 Process for the preparation of 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines
04/06/1999US5892024 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
04/06/1999US5891994 Peptides and polypeptides which induce antibodies against hiv-1 tat proteins; for vaccines; diagnosis
04/06/1999US5891890 Benzamide derivatives, anti-ulcer drug, and antibacterial drug
04/06/1999US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor
04/06/1999US5891869 Basic oxazoline-amide derivatives of GE2270 and GE2270-like antibiotics
04/06/1999US5891862 Polyvalent polymers for the treatment of rotavirus infection
04/06/1999US5891851 Antibiotic, feglymycin, processes for its preparation and its use
04/06/1999US5891705 Monomeric or oligomeric ethylenimine
04/06/1999US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development
04/06/1999US5891670 Tetracycline resistance protein
04/06/1999US5891667 SpoIIIe polynucleotides
04/06/1999US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays
04/06/1999US5891623 This method involves measuring the extent of depletion of a cd4+ t cell subtype. the subtype is defined by the expression of a particular beta chain of the t cell receptor, having a constant region and a variable region.
04/06/1999US5891442 Containing foreign dna from infectious bursal disease virus
04/06/1999US5891341 Compositions and devices for partitioning advanced glycosylation endproducts, and methods of their use
04/06/1999CA2155005C Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
04/06/1999CA2095836C Cytokine immunoconjugates
04/06/1999CA2075850C Polysulfate of beta-cyclodextrin derivative and process for preparing the same
04/06/1999CA2064190C Process for preparation of an oil in water emulsion of a drug
04/06/1999CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies
04/02/1999CA2246052A1 Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof
04/01/1999WO1999015692A2 Dengue virus antigens and treatment of dengue fever
1 ... 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 ... 1798